Olivetta Eleonora, Arenaccio Claudia, Manfredi Francesco, Anticoli Simona, Federico Maurizio
National AIDS Center, Istituto Superiore di Sanità, Viale Regina Elena, 299, 00161 Rome, Italy.
Curr Drug Targets. 2016;17(1):46-53. doi: 10.2174/1389450116666151001110126.
Nef is an accessory protein expressed exclusively in primate lentiviruses. It is devoid of enzymatic activities while interacting with several cell proteins as an adaptor/scaffold protein. Intracellular functions of Nef largely account for many pathogenic effects observed in AIDS disease. Nef, despite lacking known secretory pathways, can be detected in plasma of HIV-1-infected patients at the concentration varing from 5 to 10 ng/ml. Remarkably, the levels of Nef in plasma of HIV patients do not correlate with viral load or number of CD4(+) T lymphocytes, and persist during antiretroviral therapy. Here, we review literature data describing how Nef can be transmitted from HIV-1- infected cells to bystander ones, and the effects of extracellular Nef in different cell types. Overall, large part of experimental evidences supports the idea that extracellular Nef plays a relevant role in AIDS pathogenesis. Hence, efforts focused on the identification of Nef-inhibiting drugs would be of relevance to establish new therapeutic approaches supporting current antiretroviral therapies.
Nef是一种仅在灵长类慢病毒中表达的辅助蛋白。它没有酶活性,但作为一种衔接/支架蛋白与多种细胞蛋白相互作用。Nef的细胞内功能在很大程度上解释了艾滋病疾病中观察到的许多致病效应。尽管Nef缺乏已知的分泌途径,但在HIV-1感染患者的血浆中可以检测到,浓度在5到10纳克/毫升之间变化。值得注意的是,HIV患者血浆中Nef的水平与病毒载量或CD4(+) T淋巴细胞数量无关,并且在抗逆转录病毒治疗期间持续存在。在这里,我们回顾了文献数据,这些数据描述了Nef如何从HIV-1感染的细胞传播到旁观者细胞,以及细胞外Nef在不同细胞类型中的作用。总体而言,大部分实验证据支持细胞外Nef在艾滋病发病机制中起相关作用这一观点。因此,致力于鉴定Nef抑制药物的努力对于建立支持当前抗逆转录病毒疗法的新治疗方法具有重要意义。